慢性心力衰竭(chronic heart failure)的药物治疗取得了显著进展,但其相关发病率、死亡率和住院率仍然偏高。随着医学技术的不断发展,基于新型设备的干预已成为慢性心力衰竭的潜在治疗方法。近年来研究表明,心房分流器(interatrial shunt device)、压力反射激活治疗(baroreflex activation therapy)和膈神经刺激(phrenic nerve stimulation)在治疗慢性心力衰竭患者方面显示出了良好的前景。本文归纳总结了这些新型治疗设备的工作原理、临床研究成果,并分析其优缺点、可能的风险及未来的应用前景,旨在为临床治疗提供新的思路和参考。

Despite remarkable advances in drug therapy for chronic heart failure (CHF), the related morbidity, mortality and hospitalizations remain substantial. Novel device-based interventions have emerged as potential therapies for CHF. Recently, interatrial shunt device (IASD), baroreflex activation therapy (BAT), and phrenic nerve stimulation (PNS) have shown promise in treating patients with CHF. This article summarizes the working principles and clinical research outcomes of these innovative therapeutic devices, and analyzes their advantages and disadvantages, potential risks, and future application prospects, aiming to provide new insights and references for clinical treatment.